Inhalational system for etoposide liposomes: Formulation development and in vitro deposition

Indian Journal of Pharmaceutical Sciences

Volumn 73, Issue 6, 2011, Pages 656-662

  Parmar, J ^a,b   Singh, D ^a,b   Lohade, A ^a,b   Hegde, Darshana ^a,b   Soni, P ^a,b   Samad, A ^c   Menon, Mala ^a,b  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b Board of Radiation and Isotope Technology and Medical Cyclotron Facility   (India)

^c BOMBAY VETERINARY COLLEGE   (India)

Author keywords

Etoposide; inhalation; liposome; pulmonary delivery; twin stage impinger

Indexed keywords

ETOPOSIDE; LIPOSOME; TREHALOSE;

AEROSOL; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENVIRONMENTAL TEMPERATURE; FREEZE DRYING; HYDRATION; IN VITRO STUDY; LUNG CANCER; PARTICLE SIZE; PH MEASUREMENT; SHELF LIFE; TEMPERATURE MEASUREMENT; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84866238881     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.100240     Document Type: Article

References (18)

1. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: Recent developments and prospects. Crit Rev Ther Drug Carrier Syst 2002;19:425-98.
2. Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A. Fundamentals of pulmonary drug delivery. Respir Med 2003;97:382-7.
3. Zeng XM, Martin GP, Marriott C. The controlled delivery of drugs to the lung. Int J Pharm 1995;124:149-64.
4. Witek TJ. The Fate of Inhaled Drugs: The pharmacokinetics and pharmacodynamics of drugs administered by aerosol. Respir Care 2000;45:826-30.
5. Clark AR. Pulmonary Delivery Technology: Recent Advances and Potential for the New Millennium. In: Hickey AJ, editor. Pharmaceutical Inhalation Aerosol Technology. 2nd ed. New York: Marcel Dekker Inc.; 2004. p. 563-84.
6. Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J Pharm Sci 1986;75:433-8.
7. Shenfield GM, Evans ME, Paterson JW. Absorption of drugs by the lung. Br J Clin Pharm 1976;3:1218-23.
8. Chabner BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 9th ed. New York: The McGraw-Hill Companies Inc.; 1996. p. 1262.
9. Product Information: VePesid®, Etoposide. Princeton, NJ: Bristol Laboratories; 2000.
10. Misra A, Jinturkar K, Patel D, Lalani J, Chougule MB. Recent advances in liposomal dry powder formulations: Preparation and evaluation. Expert Opin Drug Deliv 2009;6:71-89.
11. Kellaway IW, Farr SJ. Liposomes as drug delivry to the lung. Adv Drug Deliv Rev 1990;5:149-61.
12. Joshi MR, Mishra A. Liposomal etoposide for dry powder inhaler: Preparation and stabilization. AAPS PharmSciTech 2001;2:25.
13. Smolensky MH, D'Alonzo GE, Kunkel G, Barnes PJ. Day-night patterns in bronchial patency and dyspnoea: Basis for one daily and unequally divided twice daily dosing schedules. Chronobiol Int 1987;4:303-7.
14. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across lamellae of swollen phospholipids. J Mol Biol 1965;13:238-52.
15. Fatouros D, Hatzidimitiou K, Antimisiaris S. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: Comparison of membrane integrity and drug release. Eur J Pharm Sci 2001;13: 287-96.
16. McCormack B, Gregoriadis G. Entrapment of cyclodextrin-drug complexes into liposomes: Potential advantages in drug delivery. J Drug Target 1994;2:449-54.
17. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, Calis S, Trajkovic-Jolevska S, et al. The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005;291: 79-86.
18. Zingel C, Sachse A, Robling LG, Muller HR. Lyophilization and rehydration of iopromide-carrying liposomes. Int J Pharm 1996;140: 13-24.